Bioregentech Inc

Cloudbreak Pharmaceutical is a clinical stage ophthalmic drug company based in Irvine, CA, USA. Founded in September 2015, the company specializes in developing innovative treatments for various ocular diseases, including pterygium, glaucoma, diabetic retinopathy, and age-related macular degeneration. With a team of experts possessing extensive experience in ocular drug research and development, Cloudbreak Pharmaceutical aims to improve people's vision and enhance their quality of life through the use of advanced medicines. The company's pipeline consists of a range of products at different stages of pre-clinical and clinical development, offering promising solutions for anterior and posterior segment ophthalmic diseases.Generated from the website

Rubicon Biotechnology LLC, based in Irvine, CA, is dedicated to developing novel targeted therapies aimed at significantly benefiting patient outcomes in trauma and cancer care. The company is innovating two leading-edge platform technologies: Fv-Hsp72, designed as a targeted cytoprotectant for acute indications, and Modified Annexin, focused on cancer treatment through specific targeting of tumor environments. Fv-Hsp72 seeks to mitigate cellular damage during myocardial infarction and other acute conditions, while the Modified Annexin program utilizes a unique adaptation of a natural protein to deliver anti-cancer compounds directly to solid tumors and their associated vasculature. With a seasoned executive team and strategic collaborations, Rubicon is well-positioned to advance its pioneering therapies. Generated from the website

Antigen Discovery Inc. is a research services and products company based in Irvine, CA, specializing in high throughput protein microarray technology for proteomic biomarker discovery and immune profiling. Their innovative approach significantly reduces time and cost by streamlining traditional cloning, protein expression, and screening methodologies, enabling the discovery of diagnostic biomarkers, vaccine candidates, and therapeutic antibodies. With a mission to provide exceptional services to scientists and healthcare professionals worldwide, Antigen Discovery collaborates with renowned institutions, pharmaceutical companies, and consortiums in the fields of infectious disease and vaccine development, utilizing state-of-the-art genomics and proteomics to improve lives and advance scientific knowledge.Generated from the website